JANX CIK: 1817713

Janux Therapeutics, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25

Assets

(positive)
Change from FY21 to FY25
billions USD
FY21:
0.38
FY22:
0.33
FY23:
0.35
FY24:
1.03
FY25:
0.98
(positive)
Change from FY21 to FY25
billions USD
FY21:
0.00
FY22:
0.03
FY23:
0.03
FY24:
0.03
FY25:
0.03
Total assets
Change from FY21 to FY25
billions USD
FY21:
0.38
FY22:
0.36
FY23:
0.38
FY24:
1.06
FY25:
1.00

Liabilities & Equity

(negative)
Change from FY21 to FY25
billions USD
FY21:
0.01
FY22:
0.02
FY23:
0.01
FY24:
0.02
FY25:
0.02
(negative)
Change from FY21 to FY25
billions USD
FY21:
0.00
FY22:
0.03
FY23:
0.02
FY24:
0.02
FY25:
0.02
(positive)
Change from FY21 to FY25
billions USD
FY21:
0.37
FY22:
0.32
FY23:
0.34
FY24:
1.02
FY25:
0.96
Total liabilities & equity
Change from FY21 to FY25
billions USD
FY21:
0.38
FY22:
0.36
FY23:
0.38
FY24:
1.06
FY25:
1.00

All amounts in billions USD Data source:SEC EDGAR